Fc-engineered antibody therapeutics with improved anti-SARS-CoV-2 efficacy is a research paper published in UNC Libraries (2022). On theSindex it has a DataRank of 0. It has been cited 4 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 5U19AI111825-02
Modulation of Human Dendritic Cell Development by Adjuvants and Vaccines
National Institutes of Health
Grant: 5R01AI157155-02
Human antibody-based countermeasures against the Coronavirus SARS-CoV-2
National Institutes of Health
Grant: 2P30CA008748-43
MOUSE GENETICS
National Institutes of Health
Grant: 3R01AI145870-02S1
Evaluation of the FcgR mechanisms in the antibody-dependent enhancement of SARS-CoV-2 infection
National Institutes of Health
Grant: 5R01AI137276-08
Mechanisms of Antibody-Dependent Enhancement of Dengue Disease
Fields of Study
Keywords
Sustainable Development Goals